WASHINGTON - Research-ers are using a NASA gadget to finally tell if a cataract is brewing before someone's vision clouds over.
It's a story of shot-in-the-dark science that paid off with a noninvasive test that tells when eyes are losing the natural compound that keeps cataracts at bay.
That brings the potential to fight the world's leading cause of vision loss. Knowing their eyes are vulnerable could spur people to take common-sense steps to reduce that risk, such as avoiding cigarette smoke, wearing sunglasses and improving diet.
More intriguing, the device allows easier testing of whether certain medications might prevent or slow cataract formation.
The government has only a few prototypes of the device and no commercial manufacturer lined up. But already, doctors at Baltimore's Johns Hopkins University have begun experimental use to see how the exam might fit into the care of eye patients.
"It's like an early alarm system," said Dr. Manuel Datiles III of the National Eye Institute, who led a study of 235 people that found the laser light technique can work.
It started when NASA senior scientist Rafat Ansari developed a low-powered laser light device to help astronauts with experiments growing crystals in space.
Ansari, with NASA's John Glenn Research Center in Cleveland, knew physics, not medicine. Then his father developed cataracts, where the eye's normally clear lens becomes permanently clouded.
Surprised at the lack of options, Ansari read up on cataracts and learned the lens is largely made up of proteins and water. One type of protein, called alpha-crystallin, is key to keeping it transparent. When other proteins get damaged - by the sun's UV radiation or cigarette smoke or aging - alpha-crystallins literally scoop them up before they can stick together and clog the lens. But we're born with a certain amount of alpha-crystallin. Once the supply's gone, cataracts can form.
Whoa, Ansari thought: His space laser measures proteins that make up crystals. Could it spot cataract-related proteins?
It took more than a decade of laboratory and animal testing, but the result is a machine that aims Ansari's special laser at the lens for five seconds and then calculates light scattering.
In last month's Archives of Ophthalmology, National Institutes of Health researchers report tests of 235 people ages 7 to 86. Alpha-crystallin decreased steadily both as lenses began to fog and as people with seemingly clear lenses got older.
"What we are really looking at is the reserve of this alpha-crystallin," Ansari explains. It can "repair any damage if there is a certain concentration. If it depletes below that level, then I think the game is over."
What next? NASA and NIH researchers separately are planning to study if special formulations of antioxidants - nutrients that fight certain age-related tissue damage - can slow alpha-crystallin loss.
Ansari also plans to measure the impact of long-term space travel on astronauts' vision.
Already, Datiles has used the test to diagnose cataracts beginning in some patients whose doctors found no other reason for their worsening vision.
And at Hopkins, ophthalmologist Dr. Walter Stark is using it to help tell if some patients complaining that their LASIK surgery for nearsightedness is wearing off need more vision-sharpening surgery - or if they're really forming a cataract, which LASIK can't fix. Also, researchers are testing diabetics with a cataract-speeding eye disorder.
"This test does correlate significantly with cataract formation," Stark said. "We think it has great potential."